UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Microbes and infection, ISSN 1286-4579, 03/2020, Volume 22, Issue 2, pp. 69 - 71
Novel coronavirus infection | ACE2 | Basic reproduction number (R0) | SARS | Case fatality rate | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Betacoronavirus - pathogenicity | COVID-19 | Coronavirus Infections - transmission | Pneumonia, Viral - transmission | SARS-CoV-2 | Pandemics | Coronavirus Infections - virology | Humans | Virulence | Basic Reproduction Number | Pneumonia, Viral - virology | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 07/2020, Volume 583, Issue 7818, pp. 830 - 833
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Betacoronavirus - pathogenicity | Bronchi - virology | Antigens, Viral - metabolism | Pandemics | Humans | Male | Betacoronavirus - immunology | COVID-19 | Peptidyl-Dipeptidase A - genetics | Lung - virology | SARS-CoV-2 | Lymphocytes - immunology | Immunoglobulin G - immunology | Receptors, Complement 3d - genetics | Peptidyl-Dipeptidase A - metabolism | Female | Transgenes | Bronchi - pathology | Macrophages, Alveolar - immunology | Disease Models, Animal | Macrophages, Alveolar - virology | Lung - pathology | Pneumonia, Viral - pathology | Epithelial Cells - pathology | Mice, Transgenic | Betacoronavirus - metabolism | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Angiotensin-Converting Enzyme 2 | Antigens, Viral - immunology | Animals | Coronavirus Infections - virology | Virus Replication | Weight Loss | Epithelial Cells - virology | Coronavirus Infections - pathology | Mice | Receptors, Complement 3d - metabolism | Pneumonia, Viral - virology | Lung - immunology | Genetically modified mice | Genetic aspects | Analysis | Viroids | Angiotensin converting enzyme | Pneumonia | Pathogenesis | Epithelial cells | Viral diseases | Viruses | Infections | Vaccines | Macrophages | Angiotensin-converting enzyme 2--ACE2 | Histopathology | Peptidyl-dipeptidase A | Lymphocytes | Transgenic animals | Rodents | Alveoli | Public health | Antigens | Pathogens | Severe acute respiratory syndrome | Neutrophils | Weight loss | Transgenic mice | Pharmacology | Coronaviruses | Chemical compounds | Severe acute respiratory syndrome coronavirus 2 | Pathogenicity | Lungs | Respiratory diseases | Angiotensin | Fatalities | Index Medicus
Journal Article
Cell (Cambridge), ISSN 0092-8674, 01/2021, Volume 184, Issue 1, pp. 64 - 75.e11
COVID-19 | epidemiology | SARS-CoV-2 | evolution | founder effect | spike | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Glycine - genetics | COVID-19 - virology | Genome, Viral | Spike Glycoprotein, Coronavirus - genetics | SARS-CoV-2 - growth & development | Humans | Virulence | COVID-19 - transmission | Whole Genome Sequencing | Aspartic Acid - genetics | SARS-CoV-2 - genetics | SARS-CoV-2 - pathogenicity | Aspartic Acid - analysis | Mutation | COVID-19 - epidemiology | Glycine - analysis | United Kingdom - epidemiology | Amino Acid Substitution | Index Medicus
Journal Article
Journal of medical virology, ISSN 0146-6615, 10/2020, Volume 92, Issue 10, pp. 1864 - 1874
clinical manifestations | COVID‐19 | virulence | SARS‐CoV‐2 | 2019‐nCoV | Life Sciences & Biomedicine | Science & Technology | Virology | Adaptive Immunity | Angiotensin-Converting Enzyme 2 | Cytokine Release Syndrome - virology | SARS-CoV-2 - pathogenicity | Humans | Risk Factors | COVID-19 - physiopathology | COVID-19 - mortality | Immunity, Innate | Pandemics | Disease | Control methods | Pathogenesis | Vaccination | Viral diseases | Clinical trials | Viruses | Vaccines | Cytokine storm | Risk factors | COVID-19 | Aging | Hypertension | Pathogens | Cytokines | Mortality | Severe acute respiratory syndrome | Diabetes mellitus | Coronaviruses | Risk analysis | Morbidity | Severe acute respiratory syndrome coronavirus 2 | Pathogenicity | Plague | Respiratory diseases | Angiotensin | Diagnostic systems | Cardiovascular diseases | Index Medicus
Journal Article
Molecular cell, ISSN 1097-2765, 12/2020, Volume 80, Issue 6, pp. 1055 - 1066.e6
transcriptome alteration | SARS-CoV-2 | Nsp1 | cell viability | translation inhibition mechanism | ribosome | cryo-EM | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Protein Biosynthesis | Chlorocebus aethiops | Humans | RNA, Messenger - genetics | Ribosome Subunits, Small, Eukaryotic - ultrastructure | Viral Nonstructural Proteins - genetics | Ribosome Subunits, Small, Eukaryotic - virology | SARS-CoV-2 - ultrastructure | RNA, Messenger - metabolism | Cryoelectron Microscopy | SARS-CoV-2 - genetics | Animals | RNA, Viral - genetics | COVID-19 - metabolism | SARS-CoV-2 - pathogenicity | COVID-19 - pathology | Viral Nonstructural Proteins - metabolism | RNA, Viral - metabolism | SARS-CoV-2 - metabolism | Ribosome Subunits, Small, Eukaryotic - metabolism | Vero Cells | Ribosome Subunits, Small, Eukaryotic - genetics | COVID-19 - genetics | Medical colleges | RNA | Viral proteins | Analysis | Physiological aspects | Protein biosynthesis | Health aspects | Genetic translation | Cells | Index Medicus
Journal Article
IUBMB life, ISSN 1521-6543, 10/2020, Volume 72, Issue 10, pp. 2097 - 2111
antibiotic | viral infection | COVID‐19 | SARS‐CoV‐2 | bacterial co‐infection | COVID-19 | bacterial co-infection | SARS-CoV-2 | Respiratory System - pathology | Coinfection | Klebsiella pneumoniae - drug effects | Pandemics | Haemophilus influenzae - drug effects | Humans | Respiratory System - microbiology | Host-Pathogen Interactions - immunology | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Respiratory System - virology | Bacterial Infections - virology | Streptococcus pyogenes - pathogenicity | Streptococcus pneumoniae - pathogenicity | Pseudomonas aeruginosa - pathogenicity | SARS-CoV-2 - drug effects | COVID-19 - epidemiology | Legionella pneumophila - pathogenicity | Bacterial Infections - microbiology | COVID-19 - virology | Pneumonia, Bacterial - microbiology | Streptococcus pneumoniae - drug effects | Streptococcus pyogenes - drug effects | Immunity, Innate - drug effects | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Acinetobacter baumannii - pathogenicity | Legionella pneumophila - drug effects | Pneumonia, Bacterial - epidemiology | Pneumonia, Bacterial - virology | Pseudomonas aeruginosa - drug effects | COVID-19 - drug therapy | SARS-CoV-2 - pathogenicity | COVID-19 - microbiology | Klebsiella pneumoniae - pathogenicity | Bacterial Infections - epidemiology | Respiratory System - drug effects | Pneumonia, Bacterial - drug therapy | Acinetobacter baumannii - drug effects | Haemophilus influenzae - pathogenicity | Bacterial infections | Mortality | Azithromycin | Infections | Coronaviruses | Risk factors | Severe acute respiratory syndrome coronavirus 2 | Antibiotics | Influenza | Bacteria | Viral infections | Index Medicus
Journal Article
Molecular biology and evolution, ISSN 0737-4038, 01/2021, Volume 38, Issue 2, pp. 702 - 715
SARS-CoV-2 - chemistry | Species Specificity | Viral Proteins - chemistry | Humans | SARS Virus - chemistry | SARS Virus - metabolism | Viral Proteins - metabolism | Molecular Dynamics Simulation | SARS Virus - pathogenicity | Animals | SARS-CoV-2 - pathogenicity | Proteomics | Protein Domains | SARS-CoV-2 - metabolism | Index Medicus | BASIC BIOLOGICAL SCIENCES
Journal Article